|
1
|
Carey LA, Perou CM, Livasy CA, Dressler
LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S,
et al: Race, breast cancer subtypes, and survival in the carolina
breast cancer study. JAMA. 295:2492–2502. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Foulkes WD, Stefansson IM, Chappuis PO,
Bégin LR, Goffin JR, Wong N, Trudel M and Akslen LA: Germline BRCA1
mutations and a basal epithelial phenotype in breast cancer. J Natl
Cancer Inst. 95:1482–1485. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Castiglioni F, Terenziani M, Carcangiu ML,
Miliano R, Aiello P, Bertola L, Triulzi T, Gasparini P, Camerini T,
Sozzi G, et al: Radiation effects on development of HER2-positive
breast carcinomas. Clin Cancer Res. 13:46–51. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dent R, Trudeau M, Pritchard KI, Hanna WM,
Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P and Narod SA:
Triple-negative breast cancer: Clinical features and patterns of
recurrence. Clin Cancer Res. 13:4429–4434. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hudis CA and Gianni L: Triple-negative
breast cancer: An unmet medical need. Oncologist. 16 Suppl
1:S1–S11. 2011. View Article : Google Scholar
|
|
6
|
Jia Y and Xie J: Promising molecular
mechanisms responsible for gemctiabine resistance in cancer. Genes
Dis. 2:299–306. 2015. View Article : Google Scholar
|
|
7
|
Angeloni V, Tiberio P, Appierto V and
Daidone MG: Implications of stemness-related signaling pathways in
breast cancer response to therapy. Semin Cancer Biol. 31:43–51.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Taipale J and Beachy PA: The hedgehog and
Wnt signalling pathways in cancer. Nature. 411:349–354. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Reya T and Clevers H: Wnt signalling in
stem cells and cancer. Nature. 434:843–850. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu S, Dontu G, Mantle ID, Patel S, Ahn
NS, Jackson KW, Suri P and Wicha MS: Hedgehog signaling and Bmi-1
regulate self-renewal of normal and malignant human mammary stem
cells. Cancer Res. 66:6063–6071. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Takebe N, Harris PJ, Warren RQ and Ivy SP:
Targeting cancer stem cells by inhibiting Wnt, notch, and hedgehog
pathways. Nat Rev Clin Oncol. 8:97–106. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Clevers H, Loh KM and Nusse R: Stem cell
signaling. An integral program for tissue renewal and regeneration:
Wnt signaling and stem cell control. Science. 346:12480122014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Takebe N, Warren RQ and Ivy SP: Breast
cancer growth and metastasis: Interplay between cancer stem cells,
embryonic signaling pathways and epithelial-to-mesenchymal
transition. Breast Cancer Res. 13:2112011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Flemban A and Qualtrough D: The potential
role of hedgehog signaling in the luminal/basal phenotype of breast
epithelia and in breast cancer invasion and metastasis. Cancers
(Basel). 7:1863–1884. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ingham PW and McMahon AP: Hedgehog
signaling in animal development: Paradigms and principles. Genes
Dev. 15:3059–3087. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lewis MT, Ross S, Strickland PA, Sugnet
CW, Jimenez E, Scott MP and Daniel CW: Defects in mouse mammary
gland development caused by conditional haploinsufficiency of
Patched-1. Development. 126:5181–5193. 1999.PubMed/NCBI
|
|
17
|
Kubo M, Nakamura M, Tasaki A, Yamanaka N,
Nakashima H, Nomura M, Kuroki S and Katano M: Hedgehog signaling
pathway is a new therapeutic target for patients with breast
cancer. Cancer Res. 64:6071–6074. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Moraes RC, Zhang X, Harrington N, Fung JY,
Wu MF, Hilsenbeck SG, Allred DC and Lewis MT: Constitutive
activation of smoothened (SMO) in mammary glands of transgenic mice
leads to increased proliferation, altered differentiation and
ductal dysplasia. Development. 134:1231–1242. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hui M, Cazet A, Nair R, Watkins DN,
O'Toole SA and Swarbrick A: The hedgehog signalling pathway in
breast development, carcinogenesis and cancer therapy. Breast
Cancer Res. 15:2032013. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Im S, Choi HJ, Yoo C, Jung JH, Jeon YW,
Suh YJ and Kang CS: Hedgehog related protein expression in breast
cancer: Gli-2 is associated with poor overall survival. Korean J
Pathol. 47:116–123. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Noman AS, Uddin M, Rahman MZ, Nayeem MJ,
Alam SS, Khatun Z, Wahiduzzaman M, Sultana A, Rahman ML, Ali MY, et
al: Overexpression of sonic hedgehog in the triple negative breast
cancer: Clinicopathological characteristics of high burden breast
cancer patients from Bangladesh. Sci Rep. 6:188302016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wolf I, Bose S, Desmond JC, Lin BT,
Williamson EA, Karlan BY and Koeffler HP: Unmasking of
epigenetically silenced genes reveals DNA promoter methylation and
reduced expression of PTCH in breast cancer. Breast Cancer Res
Treat. 105:139–155. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bièche I, Lerebours F, Tozlu S, Espie M,
Marty M and Lidereau R: Molecular profiling of inflammatory breast
cancer: Identification of a poor-prognosis gene expression
signature. Clin Cancer Res. 10:6789–6795. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Polakis P: Wnt signaling and cancer. Genes
Dev. 14:1837–1851. 2000.PubMed/NCBI
|
|
25
|
Nelson WJ and Nusse R: Convergence of Wnt,
beta-catenin, and cadherin pathways. Science. 303:1483–1487. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Duchartre Y, Kim YM and Kahn M: The Wnt
signaling pathway in cancer. Crit Rev Oncol Hematol. 99:141–149.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Katoh M and Katoh M: WNT signaling pathway
and stem cell signaling network. Clin Cancer Res. 13:4042–4045.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jamieson C, Sharma M and Henderson BR:
Targeting the β-catenin nuclear transport pathway in cancer. Semin
Cancer Biol. 27:20–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Clevers H: Wnt/beta-catenin signaling in
development and disease. Cell. 127:469–480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jönsson M, Borg A, Nilbert M and Andersson
T: Involvement of adenomatous polyposis coli (APC)/beta-catenin
signalling in human breast cancer. Eur J Cancer. 36:242–248. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lin SY, Xia W, Wang JC, Kwong KY, Spohn B,
Wen Y, Pestell RG and Hung MC: Beta-catenin, a novel prognostic
marker for breast cancer: Its roles in cyclin D1 expression and
cancer progression. Proc Natl Acad Sci USA. 97:4262–4266. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
King TD, Suto MJ and Li Y: The
Wnt/β-catenin signaling pathway: A potential therapeutic target in
the treatment of triple negative breast cancer. J Cell Biochem.
113:13–18. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hatsell S, Rowlands T, Hiremath M and
Cowin P: Beta-catenin and Tcfs in mammary development and cancer. J
Mammary Gland Biol Neoplasia. 8:145–158. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Huguet EL, McMahon JA, McMahon AP,
Bicknell R and Harris AL: Differential expression of human Wnt
genes 2, 3, 4, and 7B in human breast cell lines and normal and
disease states of human breast tissue. Cancer Res. 54:2615–2621.
1994.PubMed/NCBI
|
|
35
|
Benhaj K, Akcali KC and Ozturk M:
Redundant expression of canonical Wnt ligands in human breast
cancer cell lines. Oncol Rep. 15:701–707. 2006.PubMed/NCBI
|
|
36
|
Nagahata T, Shimada T, Harada A, Nagai H,
Onda M, Yokoyama S, Shiba T, Jin E, Kawanami O and Emi M:
Amplification, up-regulation and over-expression of DVL-1, the
human counterpart of the Drosophila disheveled gene, in primary
breast cancers. Cancer Sci. 94:515–518. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bànkfalvi A, Terpe HJ, Breukelmann D, Bier
B, Rempe D, Pschadka G, Krech R, Lellè RJ and Boecker W:
Immunophenotypic and prognostic analysis of E-cadherin and
beta-catenin expression during breast carcinogenesis and tumour
progression: A comparative study with CD44. Histopathology.
34:25–34. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Karayiannakis AJ, Nakopoulou L,
Gakiopoulou H, Keramopoulos A, Davaris PS and Pignatelli M:
Expression patterns of beta-catenin in in situ and invasive breast
cancer. Eur J Surg Oncol. 27:31–36. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wong SC, Lo SF, Lee KC, Yam JW, Chan JK
and Hsiao Wendy WL: Expression of frizzled-related protein and
Wnt-signalling molecules in invasive human breast tumours. J
Pathol. 196:145–153. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yang SH, Andl T, Grachtchouk V, Wang A,
Liu J, Syu LJ, Ferris J, Wang TS, Glick AB, Millar SE and Dlugosz
AA: Pathological responses to oncogenic hedgehog signaling in skin
are dependent on canonical Wnt/beta3-catenin signaling. Nat Genet.
40:1130–1135. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
41
|
He J, Sheng T, Stelter AA, Li C, Zhang X,
Sinha M, Luxon BA and Xie J: Suppressing Wnt signaling by the
hedgehog pathway through sFRP-1. J Biol Chem. 281:35598–35602.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Schneider FT, Schänzer A, Czupalla CJ,
Thom S, Engels K, Schmidt MH, Plate KH and Liebner S: Sonic
hedgehog acts as a negative regulator of {beta}-catenin signaling
in the adult tongue epithelium. Am J Pathol. 177:404–414. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Opdenaker LM, Arnold KM, Pohlig RT,
Padmanabhan JS, Flynn DC and Sims-Mourtada J: Immunohistochemical
analysis of aldehyde dehydrogenase isoforms and their association
with estrogen-receptor status and disease progression in breast
cancer. Breast Cancer (Dove Med Press). 6:205–209. 2014.PubMed/NCBI
|
|
44
|
Tao Y, Mao J, Zhang Q and Li L:
Overexpression of hedgehog signaling molecules and its involvement
in triple-negative breast cancer. Oncol Lett. 2:995–1001.
2011.PubMed/NCBI
|
|
45
|
Liu S, Duan X, Xu L, Ye J, Cheng Y, Liu Q,
Zhang H, Zhang S, Zhu S, Li T and Liu Y: Nuclear Gli1 expression is
associated with pathological complete response and event-free
survival in HER2-positive breast cancer treated with
trastuzumab-based neoadjuvant therapy. Tumour Biol. 37:4873–4881.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Colavito SA, Zou MR, Yan Q, Nguyen DX and
Stern DF: Significance of glioma-associated oncogene homolog 1
(GLI1) expression in claudin-low breast cancer and crosstalk with
the nuclear factor kappa-light-chain-enhancer of activated B cells
(NFκB) pathway. Breast Cancer Res. 16:4442014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Xu WH, Liu ZB, Yang C, Qin W and Shao ZM:
Expression of dickkopf-1 and beta-catenin related to the prognosis
of breast cancer patients with triple negative phenotype. PLoS One.
7:e376242012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Tsai CH, Chiu JH, Yang CW, Wang JY, Tsai
YF, Tseng LM, Chen WS and Shyr YM: Molecular characteristics of
recurrent triple-negative breast cancer. Mol Med Rep. 12:7326–7334.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Dey N, Barwick BG, Moreno CS,
Ordanic-Kodani M, Chen Z, Oprea-Ilies G, Tang W, Catzavelos C,
Kerstann KF, Sledge GW Jr, et al: Wnt signaling in triple negative
breast cancer is associated with metastasis. BMC Cancer.
13:5372013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Sims-Mourtada J, Izzo JG, Ajani J and Chao
KS: Sonic hedgehog promotes multiple drug resistance by regulation
of drug transport. Oncogene. 26:5674–5679. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Xia Z, Guo M, Liu H, Jiang L, Li Q, Peng
J, Li JD, Shan B, Feng P and Ma H: CBP-dependent Wnt/β-catenin
signaling is crucial in regulation of MDR1 transcription. Curr
Cancer Drug Targets. 15:519–532. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Micalizzi DS, Farabaugh SM and Ford HL:
Epithelial-mesenchymal transition in cancer: Parallels between
normal development and tumor progression. J Mammary Gland Biol
Neoplasia. 15:117–134. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Alexander CM, Goel S, Fakhraldeen SA and
Kim S: Wnt signaling in mammary glands: Plastic cell fates and
combinatorial signaling. Cold Spring Harb Perspect Biol. 4:pii:
a008037. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Kakarala M and Wicha MS: Implications of
the cancer stem-cell hypothesis for breast cancer prevention and
therapy. J Clin Oncol. 26:2813–2820. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Scimeca M, Antonacci C, Colombo D,
Bonfiglio R, Buonomo OC and Bonanno E: Emerging prognostic markers
related to mesenchymal characteristics of poorly differentiated
breast cancers. Tumour Biol. 37:5427–5435. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Maubant S, Tesson B, Maire V, Ye M,
Rigaill G, Gentien D, Cruzalegui F, Tucker GC, Roman-Roman S and
Dubois T: Transcriptome analysis of Wnt3a-treated triple-negative
breast cancer cells. PLoS One. 10:e01223332015. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Maeda O, Kondo M, Fujita T, Usami N, Fukui
T, Shimokata K, Ando T, Goto H and Sekido Y: Enhancement of
GLI1-transcriptional activity by beta-catenin in human cancer
cells. Oncol Rep. 16:91–96. 2006.PubMed/NCBI
|
|
58
|
Qualtrough D, Rees P, Speight B, Williams
AC and Paraskeva C: The hedgehog inhibitor cyclopamine reduces
β-catenin-Tcf transcriptional activity, induces E-cadherin
expression, and reduces invasion in colorectal cancer cells.
Cancers (Basel). 7:1885–1899. 2015. View Article : Google Scholar : PubMed/NCBI
|
